Latest news
REPL Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Replimune Group, Inc. - PR NewswirePR Newswire · Mon, 10 Aug 2026 14:00:00 GMTLabcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma - PR NewswirePR Newswire · Mon, 10 Aug 2026 11:00:00 GMTElanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species - PR NewswirePR Newswire · Fri, 07 Aug 2026 18:20:00 GMTGRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test - PR NewswirePR Newswire · Fri, 07 Aug 2026 15:05:00 GMTCo-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test - tradingview.comtradingview.com · Thu, 06 Aug 2026 13:30:00 GMTLabcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer - MorningstarMorningstar · Tue, 04 Aug 2026 16:00:00 GMTAspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson's Disease - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMT